Form Filed By Lian Brian
Wed, Aug 21, 2024
Go to original document
Viking Therapeutics, Inc. (VKTX)
Healthcare
Biotechnology
Insights
Coming soon
Non Derivative Transactions
2024-08-21
Common Stock, par value $0.00001 per share
Derivative conversion
M
Type
Acquired 1,000 shares @ $7.77 per share
2,355,927 shares
Direct
2024-08-21
Common Stock, par value $0.00001 per share
Sale
S
Type
Disposed 1,000 shares @ $69.90 per share
2,354,927 shares
Direct
Footnotes
1. The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 8, 2024 by the Reporting Person.
2. 25% of the shares subject to the option vested on each anniversary of the grant date.